Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients.

Nattermann J, Vogel M, Berg T, Danta M, Axel B, Mayr C, Bruno R, Tural C, Klausen G, Clotet B, Lutz T, Grünhage F, Rausch M, Nischalke HD, Schewe K, Bienek B, Haerter G, Sauerbruch T, Rockstroh JK, Spengler U; Kompetenznetz HIV/AIDS.

Hepatology. 2007 Oct;46(4):1016-25.

PMID:
17668881
2.

Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus.

Yee LJ, Tang YM, Kleiner DE, Wang D, Im K, Wahed A, Tong X, Rhodes S, Su X, Whelan RM, Fontana RJ, Ghany MG, Borg B, Liang TJ, Yang H; Virahep-C Study Group.

Hepatology. 2007 Jul;46(1):74-83.

3.

Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.

Huang Y, Feld JJ, Sapp RK, Nanda S, Lin JH, Blatt LM, Fried MW, Murthy K, Liang TJ.

Gastroenterology. 2007 Feb;132(2):733-44. Epub 2006 Nov 29.

4.

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD; Virahep-C Study Group.

Gastroenterology. 2006 Aug;131(2):470-7.

PMID:
16890601
5.

A graphical assessment of p-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q.

Mathias RA, Gao P, Goldstein JL, Wilson AF, Pugh EW, Furbert-Harris P, Dunston GM, Malveaux FJ, Togias A, Barnes KC, Beaty TH, Huang SK.

BMC Genet. 2006 Jun 14;7:38.

6.

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ.

Ann Intern Med. 2006 May 16;144(10):705-14.

PMID:
16702586
7.

Hepatitis C and liver transplantation.

Brown RS.

Nature. 2005 Aug 18;436(7053):973-8. Review.

PMID:
16107838
8.

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

Jeffers LJ, Cassidy W, Howell CD, Hu S, Reddy KR.

Hepatology. 2004 Jun;39(6):1702-8.

PMID:
15185312
9.

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.

Muir AJ, Bornstein JD, Killenberg PG; Atlantic Coast Hepatitis Treatment Group.

N Engl J Med. 2004 May 27;350(22):2265-71. Erratum in: N Engl J Med. 2004 Sep 16;351(12):1268.

10.
11.

Side effects of therapy of hepatitis C and their management.

Fried MW.

Hepatology. 2002 Nov;36(5 Suppl 1):S237-44. Review.

PMID:
12407599
12.

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK.

Lancet. 2001 Sep 22;358(9286):958-65.

PMID:
11583749
13.

Inference of population structure using multilocus genotype data.

Pritchard JK, Stephens M, Donnelly P.

Genetics. 2000 Jun;155(2):945-59.

14.

Association mapping in structured populations.

Pritchard JK, Stephens M, Rosenberg NA, Donnelly P.

Am J Hum Genet. 2000 Jul;67(1):170-81. Epub 2000 May 26.

15.

Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation.

Terry CF, Loukaci V, Green FR.

J Biol Chem. 2000 Jun 16;275(24):18138-44.

16.

Cytokines and the hepatic acute-phase response.

Ramadori G, Christ B.

Semin Liver Dis. 1999;19(2):141-55. Review.

PMID:
10422197
17.
18.

Histological grading and staging of chronic hepatitis.

Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, et al.

J Hepatol. 1995 Jun;22(6):696-9. Review. No abstract available.

PMID:
7560864

Supplemental Content

Support Center